The malaria parasite is still killing almost half a million people every year. A project has now identified a gene that holds ...
A promising new strategy for antimalarial treatment? A recent study discovers a gene regulation inhibitor that selectively ...
The parasite that causes malaria requires precise control of gene expression to progress through the various stages of its ...
Epigenetic inhibitors as a promising new antimalarial intervention strategy? A new study identifies an inhibitor of gene regulation that specifically kills the malaria pathogen.
A multinational team has identified PfSnf2L, a key epigenetic regulator in Plasmodium falciparum, the deadliest malaria ...
Scientists are exploring the key proteins and metabolic pathways in Plasmodium falciparum to develop new drugs to prevent malaria. Pink block arrows indicate the steps inhibited by antimalarial ...
The anti-malarial mAbs evaluated in trials in malaria-endemic regions target the P. falciparum sporozoite—the life stage of the parasite that is transmitted from mosquitoes to people. By binding ...
Of the handful of parasite species that cause malaria in humans, Plasmodium falciparum is the deadliest. When an infected female Anopheles mosquito feeds on a person, it injects saliva into the ...
The parasite that causes malaria requires precise control of gene expression to progress through the various stages of its ...
A study led by researchers from LMU Munich and the University of Regensburg has revealed crucial insights into the gene regulation of the malaria ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback